DSTA4637S: Clinical Trials

2 trials of DSTA4637S, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2

Follow DSTA4637S: new trials by email Literature Review of DSTA4637S trials Research Report on DSTA4637S

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Participants With Staphylococcus Aureus Bacteremia Receiving Standard-of-Care (SOC) Antibiotics
DSTA4637S, Placebo, SOC - Bacteremia
Phase 1CompletedGenentech, Inc.272017-07-132020-01-22
A Study to Investigate Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Healthy Volunteers
DSTA4637S, Placebo - Healthy Volunteer
Phase 1CompletedGenentech, Inc.302015-11-292018-03-06

Conditions studied

Bacteremia (1)

Sponsors

Genentech, Inc. (2)

Countries

United States (2)  ·  South Korea (1)  ·  Spain (1)

Results publications

PMID 30910894

NIH funding

2016 (1)